✦ LIBER ✦

Ustekinumab useful for moderate-to-severe plaque psoriasis

Book ID: 120845530
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2008
Weight: 195 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200816240-00003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PSS12 MODELING THE COST-EFFECTIVENESS OF

PSS12 MODELING THE COST-EFFECTIVENESS OF USTEKINUMAB FOR MODERATE TO SEVERE PLAQUE PSORIASIS IN US

✍ S Verma; S Dharmarajan; Y Yang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Spotlight on Ustekinumab in Moderate To

Spotlight on Ustekinumab in Moderate To Severe Plaque Psoriasis

✍ Croxtall, Jamie D. 📂 Article 📅 2012 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 276 KB

Ustekinumab: new option for moderate-to-

Ustekinumab: new option for moderate-to-severe psoriasis

✍ Steve Chaplin; Tony Downs 📂 Article 📅 2009 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 82 KB

Cost-efficacy of adalimumab, etanercept,

Cost-efficacy of adalimumab, etanercept, infliximab and ustekinumab for moderate-to-severe plaque psoriasis

✍ C. Ferrándiz; A. García; A.J. Blasco; P. Lázaro 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 242 KB

Comparison of Ustekinumab and Etanercept

Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis

✍ Griffiths, Christopher E.M.; Strober, Bruce E.; van de Kerkhof, Peter; Ho, Vince 📂 Article 📅 2010 🏛 Massachusetts Medical Society 🌐 English ⚖ 411 KB

Cost per treated patient for etanercept

Cost per treated patient for etanercept and ustekinumab in patients treated for moderate to severe plaque psoriasis

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 48 KB